Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01992172 · ClinicalTrials.gov registry record · NA
Photocil (Topical) for the Treatment of Atopic Dermatitis
A NA study, sponsored by Applied Biology.
- Completed
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT01992172 is a NA study that has completed, run by Applied Biology. The registered enrollment target is 7 participants.
The verdict
NCT01992172, a NA study, has completed, sponsored by Applied Biology.
- COMPLETED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
Photocil is a topical drug (cream) that selectively delivers Narrow Band - Ultraviolet B (NB-UVB) therapy when exposed to sunlight. Photocil is intended to help protect users from non-therapeutic Ultraviolet B (UVB) radiation while selectively passing wavelengths of light in the NB-UVB range with peak transmission of 308nm. The aim of the study is to assess the safety and efficacy of Photocil in the treatment of atopic dermatitis.
Interventions
- OTHER Placebo - Sunscreen (SPF 2)
- DRUG Photocil for Atopic Dermatitis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2013-08 |
| Est. Completion | 2014-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01992172
The ClinicalTrials.gov registry entry for NCT01992172 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Applied Biology, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo - Sunscreen (SPF 2) is the first listed.
NCT01992172 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01992172 about?
NCT01992172 is a clinical study titled "Photocil (Topical) for the Treatment of Atopic Dermatitis". Photocil is a topical drug (cream) that selectively delivers Narrow Band - Ultraviolet B (NB-UVB) therapy when exposed to sunlight. Photocil is intended to help protect users from non-therapeutic Ultraviolet B (UVB) radiation while selectively passing wavelengths of light in the NB-UVB range with pe...
What is the current status of trial NCT01992172?
This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2013-08. Estimated completion is 2014-12.
What interventions are being tested in trial NCT01992172?
The interventions under investigation include: Placebo - Sunscreen (SPF 2) (OTHER), Photocil for Atopic Dermatitis (DRUG).
Who is sponsoring clinical trial NCT01992172?
This trial is sponsored by Applied Biology, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.